New York, NY
Kate Cronin, head of the Global Healthcare Practice, is responsible for overseeing the firm’s overall healthcare and pharmaceutical business including consumer health and biotechnology.
At Ogilvy, Kate guides the Global Healthcare Practice in providing superior client service.
With 20 years experience in the health care arena, Kate has engaged clients on issues, product approvals, FDA advisory committee hearings and product labeling changes. She is also instrumental in ensuring that client needs are consistently addressed from resource allocation, service audits to financial considerations.
Prior to joining Ogilvy, Kate was head of the New York Healthcare Practice at Porter Novelli where she led a team of 60 people, provided strategic counsel to clients and developed consumer mobilization programs and physician education initiatives for clients including Novartis, Pfizer, BMS, Wyeth, Aventis and Baxter.
She has particular expertise in managing global programs, as well as prelaunch and launch initiatives for a variety of clients, including an award-winning communications plan for the Rx-to-OTC switch of Tagamet®. In addition, she managed product launches in a range of disease categories, including the central nervous system, AIDS, consumer health, hemophilia and respiratory diseases.
Experienced in building client relationships with professional and patient third-party organizations, Kate has conducted alliance building programs for several clients including Eisai and Pfizer, Biogen and Amgen.
Kate also conducted research in the field of neurobiology at Cornell University Medical College. She presented her research at the annual Society for Neuroscience meeting and has co-authored several research articles in peer-review publications, including the Journal of Comparative Neurology, the Journal of Neuroscience and Neuroscience Abstracts.
Kate earned her Bachelor of Arts degree (major in Biology) from Smith College in Northampton, Massachusetts.